@naome-natcan.bsky.social
National Audit of Metastatic Breast Cancer (NAoMe). Working to improve the quality of hospital care for patients with metastatic breast cancer in Eng & Wales.
@naome-natcan.bsky.social📰 NAoMe 2026 State of the Nation Patient and Public Version is out now: discover key insights into metastatic breast cancer care, outcomes and improvement priorities in an accessible report for patients, families and the public. 🎀 buff.ly/s2M83du #BreastCancerAudit #NAoMe
@naome-natcan.bsky.socialJoin our webinar exploring key findings from the 2026 State of the Nation Report. Hear the latest insights into metastatic breast cancer care, outcomes, and areas for improvement to support better patient experiences. 📊🎀 buff.ly/WN5sXlt #BreastCancerAudit #NAoMe
@naome-natcan.bsky.socialThis Breast Cancer Awareness Month, NAoMe is spotlighting the importance of measuring and improving metastatic breast cancer care. Audit data helps identify variation, drive improvement and support better outcomes for patients. 🎀https://buff.ly/Y6IqJR9 #BreastCancerAudit @natcan-news.bsky.social
@naome-natcan.bsky.social💊 CDK4/6 inhibitors are recommended for eligible people with ER-positive, HER2-negative metastatic breast cancer (MBC), but there is variation in use between breast units. In England, 41% of people with de novo MBC received this treatment. 📊 buff.ly/sKORFsR
@naome-natcan.bsky.social👥 All people diagnosed with metastatic breast cancer would benefit from specialist MDT review. NAoMe found MDT discussion was recorded for 81% of people in England and 68% in Wales with de novo metastatic disease buff.ly/3K7KpqD
@naome-natcan.bsky.social📰 The NAoMe State of the Nation Report 2026 is out now! Explore the latest findings on patterns of care, treatment and outcomes for people with metastatic breast cancer in England and Wales, alongside recommendations to support quality improvement. 📊 buff.ly/huAdbv9 #BreastCancerAudit #NAoMe
@naome-natcan.bsky.social👀 The NAoMe State of the Nation Report 2026 is coming on 🚨 11 September 🚨. The report presents the latest findings on patterns of care and outcomes for people with metastatic breast cancer in England and Wales. Stay tuned for key insights and recommendations. 📊 buff.ly/huAdbv9 #BreastCancerAudit
@naome-natcan.bsky.social📖 New research from our Clinical Fellow Jemma Boyle! This population-based study shines a light on breast cancer in men across England and Wales, adding important evidence to inform care, policy and future research 👏🔬🎗️https://buff.ly/Zx5iN29 #BreastCancerAudit #NAoMe @natcan-news.bsky.social
